论文部分内容阅读
为更多了解睾酮治疗Klinefelter综合征病人的效果,作者自1970～1982年期间对30例接受睾酮治疗的Klinefelter综合征患者进行了研究。应用的睾酮是:17-甲基睾酮(110mg庚酸睾酮,testosrone enantate/ml)、丙酸睾酮(testosterone proprionate,25mg)或restandol(40mg,undecanoate睾酮/片)。患者接受睾酮治疗的平均时间为3.6±3.1年。其中23例(77%)疗效明显,2例(7%)具有中等疗效,5例(17%)无效。睾酮治疗期间患者体征改善主要表现为耐力、力量、活动力及欲望力都增强,具有较好的工作、学习能力,情绪良好、能与他
To learn more about the effect of testosterone on patients with Klinefelter syndrome, the authors studied 30 Klinefelter syndrome patients receiving testosterone therapy from 1970 to 1982. Testosterone to be used is: 17-methyltestosterone (110 mg testosterone enantate / ml), testosterone proprionate (25 mg) or restandol (40 mg, undecanoate testosterone / tablet). The average duration of patients receiving testosterone was 3.6 ± 3.1 years. Of these, 23 (77%) had a significant effect, 2 (7%) had moderate efficacy and 5 (17%) had no effect. During the testosterone treatment, the improvement of the patient’s signs mainly manifested as endurance, strength, mobility and desire are enhanced, with good work and study ability, good mood, with him